Modulation of the gut microbiome: A systematic review of the effect of bariatric surgery

European Journal of Endocrinology

Volumn 178, Issue 1, 2018, Pages 43-56

  Guo, Yan ^a   Huang, Zhi Ping ^a,b   Liu, Chao Qian ^b   Qi, Lin ^c   Sheng, Yuan ^b   Zou, Da Jin ^a  

^a Department of Clinical Laboratory   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; BILE ACID; C REACTIVE PROTEIN; DEOXYCHOLIC ACID; GLUCOSE; INTERLEUKIN 6; LIPID; LITHOCHOLIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OROSOMUCOID; PHOSPHOTRANSFERASE; SHORT CHAIN FATTY ACID; TRIACYLGLYCEROL;

BACTERIAL MICROBIOME; BACTEROIDETES; BARIATRIC SURGERY; BILIO INTESTINAL BYPASS; BLAUTIA; BODY COMPOSITION; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DUODENAL JEJUNAL BYPASS; EMBASE; ENTEROBACTERIACEAE; ENTEROBACTERIALES; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; EVIDENCE BASED PRACTICE; FAECALIBACTERIUM PRAUSNITZII; FIRMICUTES; FUSOBACTERIA; GAMMAPROTEOBACTERIA; GASTROPLASTY; GENETIC ANALYSIS; GLUCOSE HOMEOSTASIS; HOST; HUMAN; ILEAL INTERPOSITION; IMMUNOMODULATION; INTESTINE BYPASS; INTESTINE FLORA; INTESTINE TRANSPLANTATION; KLEBSIELLA PNEUMONIAE; LACTOBACILLALES; LACTOBACILLUS; LIPID ANALYSIS; MEDLINE; METABOLIC PARAMETERS; MICROBIAL DIVERSITY; NONHUMAN; OUTCOME ASSESSMENT; PHYLUM; PRIORITY JOURNAL; PROTEOBACTERIA; QUALITY CONTROL; REVIEW; ROUX-EN-Y GASTRIC BYPASS; SCREENING TEST; SLEEVE GASTRECTOMY; SLEEVE GASTROPLASTY; STREPTOCOCCUS GORDONII; SYSTEMATIC REVIEW; THERAPY EFFECT; VERRUCOMICROBIA; VERTICAL BANDED GASTROPLASTY; MICROBIOLOGY; OBESITY; POSTOPERATIVE PERIOD;

BARIATRIC SURGERY; GASTROINTESTINAL MICROBIOME; HUMANS; OBESITY; POSTOPERATIVE PERIOD;

EID: 85038249655     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-17-0403     Document Type: Review

References (63)

1. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. New England Journal of Medicine 2004 351 2683-2693. (https://doi.org/10.1056/NEJMoa035622)
2. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KGMM, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 2016 39 861-877. (https://doi.org/10.2337/dc16-0236)
3. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP & Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. American Journal of Medicine 2009 122 248.e245-256.e245. (https://doi.org/10.1016/j.amjmed.2008.12.006)
4. Aron-Wisnewsky J, Dore J & Clement K. The importance of the gut microbiota after bariatric surgery. Nature Reviews Gastroenterology and Hepatology 2012 9 590-598. (https://doi.org/10.1038/nrgastro.2012.161)
5. Burcelin R, Serino M, Chabo C, Garidou L, Pomie C, Courtney M, Amar J & Bouloumie A. Metagenome and metabolism: the tissue microbiota hypothesis. Diabetes, Obesity and Metabolism 2013 15 61-70. (https://doi.org/10.1111/dom.12157)
6. Arora T & Bäckhed F. The gut microbiota and metabolic disease: current understanding and future perspectives. Journal of Internal Medicine 2016 280 339-349.
7. Magouliotis DE, Tasiopoulou VS, Sioka E, Chatedaki C & Zacharoulis D. Impact of bariatric surgery on metabolic and gut microbiota profle: a systematic review and meta-analysis. Obesity Surgery 2017 27 1345-1357.
8. Strader AD. Ileal transposition provides insight into the effectiveness of gastric bypass surgery. Physiology and Behavior 2006 88 277-282. (https://doi.org/10.1016/j.physbeh.2006.05.034)
9. Moher D, Liberati A, Tetzlaff J & Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009 339 b2535. (https://doi.org/10.1136/bmj. b2535)
10. Zhou Y, Gao J, Luo L & Wang Y. Does bruxism contribute to dental implant failure? A systematic review and meta-analysis. Clinical Implant Dentistry and Related Research 2016 18 410-420. (https://doi.org/10.1111/cid.12300)
11. Zhu H, Shen Z, Luo H, Zhang W & Zhu X. Chlamydia trachomatis infection-associated risk of cervical cancer: a meta-analysis. Medicine 2016 95 e3077. (https://doi.org/10.1097/MD.0000000000003077)
12. Kilkenny C, Browne WJ, Cuthill IC, Emerson M & Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biology 2010 8 e1000412. (https://doi.org/10.1371/journal.pbio.1000412)
13. Scholten-Peeters GGM, Verhagen AP, Bekkering GE, van der Windt DAWM, Barnsley L, Oostendorp RAB & Hendriks EJM. Prognostic factors of whiplash-associated disorders: a systematic review of prospective cohort studies. Pain 2003 104 303-322. (https://doi.org/10.1016/S0304-3959(03)00050-2)
14. Kuijpers T, van der Windt DA, van der Heijden GJ & Bouter LM. Systematic review of prognostic cohort studies on shoulder disorders. Pain 2004 109 420-431. (https://doi.org/10.1016/j.pain.2004.02.017)
15. Mols F, Vingerhoets AJ, Coebergh JW & van de Poll-Franse LV. Quality of life among long-term breast cancer survivors: a systematic review. European Journal of Cancer 2005 41 2613-2619. (https://doi.org/10.1016/j.ejca.2005.05.017)
16. Oczkowski SJ, Chung HO, Hanvey L, Mbuagbaw L & You JJ. Communication tools for end-of-life decision-making in the intensive care unit: a systematic review and meta-analysis. Critical Care 2016 20 97. (https://doi.org/10.1186/s13054-016-1264-y)
17. Chao A. Nonparametric estimation of the number of classes in a population. Scandinavian Journal of Statistics 1984 11 265-270.
18. Kong LC, Tap J, Aron-Wisnewsky J, Pelloux V, Basdevant A, Bouillot JL, Zucker JD, Dore J & Clement K. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. American Journal of Clinical Nutrition 2013 98 16-24. (https://doi.org/10.3945/ajcn.113.058743)
19. Guo Y, Liu CQ, Shan CX, Chen Y, Li HH, Huang ZP & Zou DJ. Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: increased diversity and associations of discriminant genera with metabolic changes. Diabetes/Metabolism Research and Reviews 2016 33 1-8. (https://doi.org/10.1002/dmrr.2857)
20. Patrone V, Vajana E, Minuti A, Callegari ML, Federico A, Loguercio C, Dallio M, Tolone S, Docimo L & Morelli L. Postoperative changes in fecal bacterial communities and fermentation products in obese patients undergoing bilio-intestinal bypass. Frontiers in Microbiology 2016 7 200.
21. Murphy R, Tsai P, Jullig M, Liu A, Plank L & Booth M. Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission. Obesity Surgery 2016 27 917-925.
22. Palleja A, Kashani A, Allin KH, Nielsen T, Zhang C, Li Y, Brach T, Liang S, Feng Q, Jorgensen NB et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Medicine 2016 8 67. (https://doi.org/10.1186/s13073-016-0312-1)
23. Basso N, Soricelli E, Castagneto-Gissey L, Casella G, Albanese D, Fava F, Donati C, Tuohy K, Angelini G, La Neve F et al. Insulin resistance, microbiota and fat distribution changes by a new model of vertical sleeve gastrectomy in obese rats. Diabetes 2016 61 2990-3001. (https://doi.org/10.2337/db16-0039)
24. Ward EK, Schuster DP, Stowers KH, Royse AK, Ir D, Robertson CE, Frank DN & Austin GL. The effect of PPI use on human gut microbiota and weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass. Obesity Surgery 2014 24 1567-1571. (https://doi.org/10.1007/s11695-014-1275-1)
25. Shao Y, Ding R, Xu B, Hua R, Shen Q, He K & Yao Q. Alterations of gut microbiota after roux-en-Y gastric bypass and sleeve gastrectomy in Sprague-Dawley rats. Obesity Surgery 2016 27 295-302.
26. Graessler J, Qin Y, Zhong H, Zhang J, Licinio J, Wong ML, Xu A, Chavakis T, Bornstein AB, Ehrhart-Bornstein M et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with infammatory and metabolic parameters. Pharmacogenomics Journal 2013 13 514-522. (https://doi.org/10.1038/tpj.2012.43)
27. Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ & Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Science Translational Medicine 2013 5 178ra141.
28. Zhang X, Wang Y, Zhong M, Liu T, Han H, Zhang G, Liu S, Wei M, Wu Q & Hu S. Duodenal-jejunal bypass preferentially elevates serum taurine-conjugated bile acids and alters gut microbiota in a diabetic rat model. Obesity Surgery 2015 26 1890-1899.
29. Li JV, Ashrafan H, Bueter M, Kinross J, Sands C, le Roux CW, Bloom SR, Darzi A, Athanasiou T, Marchesi JR et al. Metabolic surgery profoundly infuences gut microbial-host metabolic cross-talk. Gut 2011 60 1214-1223. (https://doi.org/10.1136/gut.2010.234708)
30. Tremaroli V, Karlsson F, Werling M, Stahlman M, Kovatcheva-Datchary P, Olbers T, Fandriks L, Le Roux CW, Nielsen J & Backhed F. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metabolism 2015 22 228-238. (https://doi.org/10.1016/j.cmet.2015.07.009)
31. Huang X, Weng P, Zhang H & Lu Y. Remodeling intestinal fora with sleeve gastrectomy in diabetic rats. Journal of Diabetes Research 2014 2014 196312.
32. Jiang S, Wang Q, Huang Z, Song A, Peng Y, Hou S, Guo S, Zhu W, Yan S, Lin Z et al. Gastric bypass surgery reverses diabetic phenotypes in Bdnf-defcient mice. American Journal of Pathology 2016 186 2117-2128. (https://doi.org/10.1016/j.ajpath.2016.04.009)
33. Kashihara H, Shimada M, Yoshikawa K, Higashijima J, Nakao T, Nishi M & Takasu C. Duodenal-jejunal bypass changes the composition of the gut microbiota. Surgery Today 2016 47 137-140.
34. Cummings BP, Bettaieb A, Graham JL, Kim J, Ma F, Shibata N, Stanhope KL, Giulivi C, Hansen F, Jelsing J et al. Bile-acid-mediated decrease in endoplasmic reticulum stress: a potential contributor to the metabolic benefts of ileal interposition surgery in UCD-T2DM rats. Disease Models and Mechanisms 2013 6 443-456. (https://doi.org/10.1242/dmm.010421)
35. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, Crowell MD, Wing R, Rittmann BE et al. Human gut microbiota in obesity and after gastric bypass. PNAS 2009 106 2365-2370. (https://doi.org/10.1073/pnas.0812600106)
36. Damms-Machado A, Mitra S, Schollenberger AE, Kramer KM, Meile T, Konigsrainer A, Huson DH & Bischoff SC. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. BioMed Research International 2015 2015 806248.
37. Miyachi T, Nagao M, Shibata C, Kitahara Y, Tanaka N, Watanabe K, Tsuchiya T, Motoi F, Naitoh T & Unno M. Biliopancreatic limb plays an important role in metabolic improvement after duodenal-jejunal bypass in a rat model of diabetes. Surgery 2016 159 1360-1371.
38. Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, Mariat D, Corthier G, Dore J, Henegar C et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade infammation markers. Diabetes 2010 59 3049-3057. (https://doi.org/10.2337/db10-0253)
39. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP et al. A core gut microbiome in obese and lean twins. Nature 2009 457 480-484. (https://doi.org/10.1038/nature07540)
40. Turnbaugh PJ, Backhed F, Fulton L & Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host and Microbe 2008 3 213-223. (https://doi.org/10.1016/j.chom.2008.02.015)
41. Le Roux CW, Bueter M, Theis N, Werling M, Ashrafan H, Lowenstein C, Athanasiou T, Bloom SR, Spector AC, Olbers T et al. Gastric bypass reduces fat intake and preference. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 2011 301 R1057-R1066. (https://doi.org/10.1152/ajpregu.00139.2011)
42. Carvalho BM, Guadagnini D, Tsukumo DM, Schenka AA, Latuf-Filho P, Vassallo J, Dias JC, Kubota LT, Carvalheira JB & Saad MJ. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 2012 55 2823-2834. (https://doi.org/10.1007/s00125-012-2648-4)
43. Mitchell WJ. The phosphotransferase system in solventogenic clostridia. Journal of Molecular Microbiology and Biotechnology 2015 25 129-142. (https://doi.org/10.1159/000375125)
44. Kucerova P & Cervinkova M. Spontaneous regression of tumour and the role of microbial infection-possibilities for cancer treatment. Anticancer Drugs 2016 27 269-277. (https://doi.org/10.1097/CAD.0000000000000337)
45. Stock I. Tetanus and Clostridium tetani-a brief review. Medizinische Monatsschrift für Pharmazeuten 2015 38 57-60.
46. Omernik A & Plusa T. Toxins of Clostridium perfringens as a natural and bioterroristic threats. Polski Merkuriusz Lekarski 2015 39 149-152.
47. Bordeleau E & Burrus V. Cyclic-di-GMP signaling in the gram-positive pathogen Clostridium diffcile. Current Genetics 2015 61 497-502. (https://doi.org/10.1007/s00294-015-0484-z)
48. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G et al. Faecalibacterium prausnitzii is an anti-infammatory commensal bacterium identifed by gut microbiota analysis of Crohn disease patients. PNAS 2008 105 16731-16736. (https://doi.org/10.1073/pnas.0804812105)
49. Wright EK, Kamm MA, Teo SM, Inouye M, Wagner J & Kirkwood CD. Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review. Infammatory Bowel Diseases 2015 21 1219-1228.
50. Scheepers LE, Penders J, Mbakwa CA, Thijs C, Mommers M & Arts IC. The intestinal microbiota composition and weight development in children: the KOALA Birth Cohort Study. International Journal of Obesity 2015 39 16-25. (https://doi.org/10.1038/ijo.2014.178)
51. Chen CY, Chen SW & Wang HT. Effect of supplementation of yeast with bacteriocin and Lactobacillus culture on growth performance, cecal fermentation, microbiota composition, and blood characteristics in broiler chickens. Asian-Australasian Journal of Animal Sciences 2016 30 211-220.
52. Park K, Mera PE, Escalante-Semerena JC & Brunold TC. Resonance Raman spectroscopic study of the interaction between Co(II)rrinoids and the ATP: corrinoid adenosyltransferase PduO from Lactobacillus reuteri. Journal of Biological Inorganic Chemistry 2016 21 669-681.
53. Urmann K, Arshavsky-Graham S, Walter JG, Scheper T & Segal E. Whole-cell detection of live lactobacillus acidophilus on aptamer-decorated porous silicon biosensors. Analyst 2016 141 5432-5440.
54. Hazenberg MP, van de Merwe JP, Pena AS, Pennock-Schroder AM & van Lieshout LM. Antibodies to Coprococcus comes in sera of patients with Crohn's disease. Isolation and purifcation of the agglutinating antigen tested with an ELISA technique. Journal of Clinical and Laboratory Immunology 1987 23 143-148.
55. Van de Merwe JP & Stegeman JH. Binding of Coprococcus comes to the Fc portion of IgG. A possible role in the pathogenesis of Crohn's disease? European Journal of Immunology 1985 15 860-863. (https://doi.org/10.1002/eji.1830150823)
56. Hazenberg MP, Pennock-Schroder AM & van de Merwe JP. Culturing and extraction of Coprococcus comes, absorption of serumagglutinins by soluble fractions and relation between agglutinins and antibodies in sera of patients with Crohn's disease. Medical Microbiology and Immunology 1986 175 299-306. (https://doi.org/10.1007/BF02126051)
57. Severijnen AJ, Hazenberg MP & van de Merwe JP. Induction of chronic arthritis in rats by cell wall fragments of anaerobic coccoid rods isolated from the faecal fora of patients with Crohn's disease. Digestion 1988 39 118-125. (https://doi.org/10.1159/000199614)
58. Penney NC, Kinross J, Newton RC & Purkayastha S. The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. International Journal of Obesity 2015 39 1565-1574. (https://doi.org/10.1038/ijo.2015.115)
59. Islam KB, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, Ogura Y, Hayashi T & Yokota A. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011 141 1773-1781. (https://doi.org/10.1053/j.gastro.2011.07.046)
60. Le CE, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM & Kennedy S. Richness of human gut microbiome correlates with metabolic markers. Nature 2013 500 541-546. (https://doi.org/10.1038/nature12506)
61. Albaugh VL, Flynn CR, Tamboli RA & Abumrad NN. Recent advances in metabolic and bariatric surgery. F1000Research 2016 5.
62. Oh TJ, Ahn CH & Cho YM. Contribution of the distal small intestine to metabolic improvement after bariatric/metabolic surgery: lessons from ileal transposition surgery. Journal of Diabetes Investigation 2016 7 94-101. (https://doi.org/10.1111/jdi.12444)
63. Osto M, Abegg K & Bueter M le Roux CW Cani PD Lutz TA Roux-en-Y gastric bypass surgery in rats alters gut microbiota profle along the intestine. Physiology & Behavior 2013 119 92-96. (https://doi.org/10.1016/j.physbeh.2013.06.008)